Austco Healthcare Limited, together with its subsidiaries, manufactures, distributes, supplies, and services healthcare and communication equipment and software in Australia, New Zealand, Asia, Europe, and North America.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.14|
|52 Week High||AU$0.085|
|52 Week Low||AU$0.17|
|1 Month Change||0%|
|3 Month Change||0%|
|1 Year Change||49.49%|
|3 Year Change||55.91%|
|5 Year Change||62.92%|
|Change since IPO||-51.67%|
Recent News & Updates
Returns On Capital Are Showing Encouraging Signs At Austco Healthcare (ASX:AHC)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Here's Why I Think Austco Healthcare (ASX:AHC) Might Deserve Your Attention Today
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Can Austco Healthcare (ASX:AHC) Continue To Grow Its Returns On Capital?
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
|AHC||AU Medical Equipment||AU Market|
Return vs Industry: AHC exceeded the Australian Medical Equipment industry which returned -7.4% over the past year.
Return vs Market: AHC exceeded the Australian Market which returned 24.4% over the past year.
Stable Share Price: AHC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: AHC's weekly volatility (7%) has been stable over the past year.
About the Company
Austco Healthcare Limited, together with its subsidiaries, manufactures, distributes, supplies, and services healthcare and communication equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP based nurse call solution for healthcare, aged care, and acute care facilities. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020.
Austco Healthcare Fundamentals Summary
|AHC fundamental statistics|
Is AHC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AHC income statement (TTM)|
|Cost of Revenue||AU$14.54m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.012|
|Net Profit Margin||10.96%|
How did AHC perform over the long term?See historical performance and comparison
Is Austco Healthcare undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AHC (A$0.15) is trading below our estimate of fair value (A$0.22)
Significantly Below Fair Value: AHC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AHC is good value based on its PE Ratio (12x) compared to the Australian Medical Equipment industry average (13.6x).
PE vs Market: AHC is good value based on its PE Ratio (12x) compared to the Australian market (20x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AHC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AHC is good value based on its PB Ratio (2.1x) compared to the AU Medical Equipment industry average (4.5x).
How is Austco Healthcare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Austco Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Austco Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AHC has a large one-off gain of A$2.0M impacting its June 30 2021 financial results.
Growing Profit Margin: AHC's current net profit margins (11%) are higher than last year (7.9%).
Past Earnings Growth Analysis
Earnings Trend: AHC has become profitable over the past 5 years, growing earnings by 74% per year.
Accelerating Growth: AHC's earnings growth over the past year (36.7%) is below its 5-year average (74% per year).
Earnings vs Industry: AHC earnings growth over the past year (36.7%) underperformed the Medical Equipment industry 74.9%.
Return on Equity
High ROE: AHC's Return on Equity (17.7%) is considered low.
How is Austco Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: AHC's short term assets (A$21.7M) exceed its short term liabilities (A$7.2M).
Long Term Liabilities: AHC's short term assets (A$21.7M) exceed its long term liabilities (A$643.0K).
Debt to Equity History and Analysis
Debt Level: AHC is debt free.
Reducing Debt: AHC has no debt compared to 5 years ago when its debt to equity ratio was 16.4%.
Debt Coverage: AHC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AHC has no debt, therefore coverage of interest payments is not a concern.
What is Austco Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AHC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AHC's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Clayton Astles has been the Chief Executive Officer of Austco Healthcare Limited (formerly known as Azure Healthcare Limited) since July 31, 2015 and serves as its Managing Director. Mr. Astles serves...
CEO Compensation Analysis
Compensation vs Market: Clayton's total compensation ($USD593.15K) is above average for companies of similar size in the Australian market ($USD301.38K).
Compensation vs Earnings: Clayton's compensation has been consistent with company performance over the past year.
Experienced Board: AHC's board of directors are considered experienced (6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AHC insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Austco Healthcare Limited's employee growth, exchange listings and data sources
- Name: Austco Healthcare Limited
- Ticker: AHC
- Exchange: ASX
- Founded: 1986
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: AU$42.628m
- Shares outstanding: 284.19m
- Website: https://www.austcohealthcare.com
Number of Employees
- Austco Healthcare Limited
- 1/31 Sabre Drive
- Port Melbourne
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/26 07:01|
|End of Day Share Price||2021/10/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.